See what members are saying about ITP treatments, the side effects to expect, and the drug basics.
All treatment information is medically reviewed · July 24, 2026
Nplate (romiplostim) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat low platelet counts in adults and children ages 1 and older with immune thrombocytopenia (ITP).
Privigen (immune globulin intravenous [human]) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat low platelet counts in people aged 15 years and older with chronic immune thrombocytopenic purpura (ITP).
Promacta (eltrombopag) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat low platelet counts in children ages 1 year and older with persistent or chronic immune thrombocytopenia (ITP).
Tavalisse (fostamatinib disodium hexahydrate) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic immune thrombocytopenia (ITP).
Wayrilz (rilzabrutinib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with persistent or chronic immune thrombocytopenia (ITP).
WinRho SDF (Rho[D] immune globulin intravenous [human]) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to help raise platelet counts in certain children and adults with immune thrombocytopenic purpura (ITP).
Become a member to get even more